文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Model for end-stage liver disease-Na score or Maddrey discrimination function index, which score is best?

作者信息

Amieva-Balmori Mercedes, Mejia-Loza Scherezada María Isabel, Ramos-González Roberto, Zamarripa-Dorsey Felipe, García-Ruiz Eli, Pérez Y López Nuria, Juárez-Valdés Eumir I, López-Luria Adriana, Remes-Troche José María

机构信息

Mercedes Amieva-Balmori, Scherezada María Isabel Mejia-Loza, Roberto Ramos-González, Felipe Zamarripa-Dorsey, Eli García-Ruiz, Nuria Pérez y López, Eumir I Juárez-Valdés, Adriana López-Luria, Servicio de Gastroenterología, Instituto de Investigaciones Médico-Biológicas de la Universidad Veracruzana, Hospital Juárez de México, Ciudad de México 07760, México.

出版信息

World J Hepatol. 2015 Aug 18;7(17):2119-26. doi: 10.4254/wjh.v7.i17.2119.


DOI:10.4254/wjh.v7.i17.2119
PMID:26301054
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4539405/
Abstract

AIM: To compare the ability of model for end-stage liver disease (MELD)-Na and Maddrey discrimination function index (DFI) to predict mortality at 30 and 90 d in patients with alcoholic hepatitis (AH). METHODS: We prospectively assessed 52 patients with AH. Demographic, clinical and laboratory parameters were obtained. MELD-Na and Maddrey DFI were calculated on admission. Short-term mortality was assessed at 30 and 90 d. Receiver operating characteristic curve analysis was performed. RESULTS: Thirty-day and 90-d mortality was 44% and 58%, respectively. In the univariate analysis, sodium levels was associated with mortality at 30 and 90 d (P = 0.001 and P = 0.03). Child stage, encephalopathy, ascites, or types of treatment were not associated with mortality. MELD-Na was the only predictive factor for mortality at 90 d. For 30-d mortality area under the curve (AUC) was 0.763 (95%CI: 0.63-0.89) for Maddrey DFI and 0.784 for MELD-Na (95%CI: 0.65-0.91, P = 0.82). For 90-d mortality AUC was 0.685 (95%CI: 0.54-0.83) for Maddrey DFI and 0.8710 for MELD-Na (95%CI: 0.76-0.97, P = 0.041). CONCLUSION: AH is associated with high short-term mortality. Our results show that MELD-Na is a more valuable model than DFI to predict short-term mortality.

摘要

相似文献

[1]
Model for end-stage liver disease-Na score or Maddrey discrimination function index, which score is best?

World J Hepatol. 2015-8-18

[2]
Evaluation of MELD score and Maddrey discriminant function for mortality prediction in patients with alcoholic hepatitis.

Hepatogastroenterology. 2013

[3]
Assessment of the Model for End-stage Liver Disease (MELD) Score in Predicting Prognosis of Patients with Alcoholic Hepatitis.

J Clin Exp Hepatol. 2014-3

[4]
The MELD Score Is Superior to the Maddrey Discriminant Function Score to Predict Short-Term Mortality in Alcohol-Associated Hepatitis: A Global Study.

Am J Gastroenterol. 2022-2-1

[5]
Model for end-stage liver disease score versus Maddrey discriminant function score in assessing short-term outcome in alcoholic hepatitis.

J Gastroenterol Hepatol. 2014-3

[6]
[MELD or Maddrey?: comparison of two prognosis models in patients with alcohol toxic hepatitis].

Rev Gastroenterol Mex. 2008

[7]
The Model for End-stage Liver Disease 3.0 is not superior to the Model for End-stage Liver Disease-Na in predicting survival: A retrospective cohort study.

Hepatol Commun. 2023-10-1

[8]
Risk factors for mortality in patients with alcoholic hepatitis and assessment of prognostic models: A population-based study.

Can J Gastroenterol Hepatol. 2015-4

[9]
MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis.

JHEP Rep. 2023-3-15

[10]
Predicting utility of a model for end stage liver disease in alcoholic liver disease.

World J Gastroenterol. 2006-7-7

引用本文的文献

[1]
Prognostic challenges in alcoholic hepatitis: From scoring systems to clinical predictors.

World J Hepatol. 2025-5-27

[2]
Emerging Noninvasive Biomarkers, and Medical Management Strategies for Alcoholic Hepatitis: Present Understanding and Scope.

Cells. 2020-2-25

[3]
Hyponatremia in patients with liver diseases: not just a cirrhosis-induced hemodynamic compromise.

Hepatol Int. 2016-9

本文引用的文献

[1]
Trends in Alcoholic Hepatitis-related Hospitalizations, Financial Burden, and Mortality in the United States.

J Clin Gastroenterol. 2015-7

[2]
Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort.

Aliment Pharmacol Ther. 2014-4

[3]
Alkaline phosphatase: the next independent predictor of the poor 90-day outcome in alcoholic hepatitis.

Biomed Res Int. 2013-9-17

[4]
Model for end-stage liver disease score versus Maddrey discriminant function score in assessing short-term outcome in alcoholic hepatitis.

J Gastroenterol Hepatol. 2014-3

[5]
The management of alcoholic hepatitis: a prospective comparison of scoring systems.

Aliment Pharmacol Ther. 2013-7-23

[6]
Evaluation of MELD score and Maddrey discriminant function for mortality prediction in patients with alcoholic hepatitis.

Hepatogastroenterology. 2013

[7]
Evaluation of the prognosis of fulminant viral hepatitis in late pregnancy by the MELD scoring system.

Eur J Clin Microbiol Infect Dis. 2012-5-9

[8]
Alcoholic hepatitis: a clinician's guide.

Clin Liver Dis. 2012-5

[9]
Management of alcoholic hepatitis.

J Hepatol. 2012

[10]
Alcoholic hepatitis: prognostic models and treatment.

Gastroenterol Clin North Am. 2011-9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索